Does TOFACITINIB Cause Joint dislocation? 685 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 685 reports of Joint dislocation have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.4% of all adverse event reports for TOFACITINIB.
685
Reports of Joint dislocation with TOFACITINIB
0.4%
of all TOFACITINIB reports
238
Deaths
210
Hospitalizations
How Dangerous Is Joint dislocation From TOFACITINIB?
Of the 685 reports, 238 (34.7%) resulted in death, 210 (30.7%) required hospitalization, and 141 (20.6%) were considered life-threatening.
Is Joint dislocation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 685 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Joint dislocation?
ADALIMUMAB (1,549)
ETANERCEPT (802)
METHOTREXATE (792)
ABATACEPT (656)
TOCILIZUMAB (646)
CERTOLIZUMAB PEGOL (577)
GOLIMUMAB (572)
RITUXIMAB (557)
DICLOFENAC (536)
SULFASALAZINE (536)
Which TOFACITINIB Alternatives Have Lower Joint dislocation Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN